Skip to search formSkip to main contentSkip to account menu

sibutramine

Known as: Sibutramina, Sibutraminum, sibutramine [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

19 relations
Anorexia NervosaAppetite Suppression [PE]Cerebrovascular accidentCongestive heart failure

Broader (3)

Antidepressive AgentsAppetite DepressantsCyclobutanes

Narrower (5)

BTS 54 524MeridiaReductilSIBUTRAMINE HYDROCHLORIDE

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine
Review
2013
Review
2013
Ghrelin at the interface of obesity and reward.
2013
2013
Screening of pharmacologic adulterant classes in herbal formulations using voltammetry of microparticles.
Review
2012
Review
2012
Current and Emerging Directions in the Treatment of Eating Disorders
Eating disorders are a significant source of psychiatric morbidity in young women and demonstrate high comorbidity with mood… 
2010
2010
The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women
Given the suggestion that many potential anti-obesity drugs may enhance within-meal satiation, few studies have directly measured… 
Review
2007
Review
2007
Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Highly Cited
2006
Highly Cited
2006
Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients
Background:  Early weight loss is generally considered to predict long‐term weight outcome in obese patients, and this is… 
Review
2001
Review
2001
Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders.
Highly Cited
2001
Highly Cited
2001
Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats.
Tachyphylaxis to the effects of anorexigenic agents, such as sibutramine (S), may be due, in part, to counterregulatory decreases… 
2000
2000
Abuse liability assessment of sibutramine, a novel weight control agent
Abstract Rationale: Sibutramine (Meridia) is a serotonin and norepinephrine reuptake inhibitor marketed for weight control… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)